Velliq Pharmaceuticals Private Limited
Founded in 2020 and headquartered in Telangana, India.
2020 | Hyderabad, Telangana (India) | Active
Velliq Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 154.38%
- Profit Growth 0.71%
- Ebitda 320.76%
- Net Worth 34.20%
- Total Assets 16.35%
About Velliq Pharmaceuticals
Velliq Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 April 2020 (Four years and ten months 19 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivasulu Ekambaram and Malathi Ekambaram serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51900TG2020PTC140074
- Company No.
140074
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Trading
Who are the key members and board of directors at Velliq Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasulu Ekambaram  | Director | 09-Apr-2020 | Current |
| Malathi Ekambaram | Director | 09-Apr-2020 | Current |
Financial Performance of Velliq Pharmaceuticals.
Velliq Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 154.38% increase. The company also saw a slight improvement in profitability, with a 0.71% increase in profit. The company's net worth Soared by an impressive increase of 34.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Velliq Pharmaceuticals?
Unlock access to Velliq Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Velliq Pharmaceuticals?
Velliq Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Velliq Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Velliq Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.